Literature DB >> 11445550

Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide.

G Vielhaber1, L Brade, B Lindner, S Pfeiffer, R Wepf, U Hintze, K P Wittern, H Brade.   

Abstract

Ceramide is a pivotal molecule in signal transduction and an essential structural component of the epidermal permeability barrier. The epidermis is marked by a high concentration of ceramide and by a unique spectrum of ceramide species: Besides the two ceramide structures commonly found in mammalian tissue, N-acylsphingosine and N-2-hydroxyacyl-sphingosine, six additional ceramides differing in the grade of hydroxylation of either the sphingosine base or the fatty acid have been identified in the epidermis. Here we report on the characterization of an IgM-enriched polyclonal mouse serum against ceramide. In dot blot assays with purified epidermal lipids the antiserum bound to a similar extent to N-acyl-sphingosine (ceramide 2), N-acyl-4-hydroxysphinganine (ceramide 3), and N-(2-hydroxyacyl)-sphingosine (ceramide 5), whereas no specific reaction was detected with glycosylceramides, sphingomyelin, free sphingosine, phospholipids, or cholesterol. In contrast, a monoclonal IgM antibody, also claimed to be specific for ceramide, was shown to bind specifically to sphingomyelin and therefore was not further investigated. In thin-layer chromatography immunostaining with purified lipids a strong and highly reproducible reaction of the antiserum with ceramide 2 and ceramide 5 was observed, whereas the reaction with ceramide 1 and ceramide 3 was weaker and more variable. Ceramide 2 and ceramide 5 were detected in the nanomolar range at serum dilutions of up to 1:100 by dot blot and thin-layer immunostaining. In thin-layer chromatography immunostaining of crude lipid extracts from human epidermis, the antiserum also reacted with N-(2-hydroxyacyl)-4-hydroxysphinganine (ceramide 6) and N-(2-hydroxyacyl)-6-hydroxysphingosine (ceramide 7). Furthermore, the suitability of the antiserum for the detection of endogenous ceramide by immunolight microscopy was demonstrated on cryoprocessed human skin tissue. Double immunofluorescence labeling experiments with the anti-ceramide antiserum and the recently described anti-glucosylceramide antiserum (Brade et al., 2000, Glycobiology 10, 629) showed that both lipids are concentrated in separate epidermal sites. Whereas anti-ceramide stained the dermal and basal epidermal cells as well as the corneocytes, anti-glucosylceramide staining was concentrated in the stratum granulosum. In conclusion, the specificity and sensitivity of the reagent will enable studies on the subcellular distribution and biological functions of endogenous ceramide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445550     DOI: 10.1093/glycob/11.6.451

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  11 in total

1.  Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.

Authors:  Leonardo Nimrichter; Mariana D Cerqueira; Eduardo A Leitão; Kildare Miranda; Ernesto S Nakayasu; Sandro R Almeida; Igor C Almeida; Celuta S Alviano; Eliana Barreto-Bergter; Marcio L Rodrigues
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.

Authors:  SunJa Kim; Andrew J Steelman; Yumin Zhang; Hannah C Kinney; Jianrong Li
Journal:  Brain Pathol       Date:  2011-08-16       Impact factor: 6.508

3.  Recruitment of a phospholipase C/sphingomyelinase into non-lamellar lipid droplets during hydrolysis of lipid bilayers.

Authors:  Maitane Ibarguren; Jesús Sot; L Ruth Montes; Adriana I Vasil; Michael L Vasil; Félix M Goñi; Alicia Alonso
Journal:  Chem Phys Lipids       Date:  2012-12-17       Impact factor: 3.329

4.  Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies.

Authors:  Nicole O'Brien; S Tarran Jones; David G Williams; H Brad Cunningham; Kelli Moreno; Barbara Visentin; Angela Gentile; John Vekich; William Shestowsky; Masao Hiraiwa; Rosalia Matteo; Amy Cavalli; Douglas Grotjahn; Maria Grant; Geneviève Hansen; Mary-Ann Campbell; Roger Sabbadini
Journal:  J Lipid Res       Date:  2009-06-09       Impact factor: 5.922

5.  Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain development.

Authors:  Guanghu Wang; Kannan Krishnamurthy; Ying-Wei Chiang; Somsankar Dasgupta; Erhard Bieberich
Journal:  J Neurochem       Date:  2008-05-02       Impact factor: 5.372

6.  Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.

Authors:  Gabriella Wojewodka; Juan B De Sanctis; Danuta Radzioch
Journal:  J Lipids       Date:  2010-12-28

7.  Mass spectrometry coupled to imaging techniques: the better the view the greater the challenge.

Authors:  Gwendolyn Barceló-Coblijn; José A Fernández
Journal:  Front Physiol       Date:  2015-01-22       Impact factor: 4.566

8.  Sphingolipids are required for efficient triacylglycerol loss in conjugated linoleic Acid treated adipocytes.

Authors:  Wei Wang; Michael Fromm
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

9.  Neutral sphingomyelinase 2 controls exosome secretion by counteracting V-ATPase-mediated endosome acidification.

Authors:  Dolma Choezom; Julia Christina Gross
Journal:  J Cell Sci       Date:  2022-02-28       Impact factor: 5.285

10.  Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall.

Authors:  Wenjing Li; Xiaoyan Yang; Shasha Xing; Fang Bian; Wanjing Yao; Xiangli Bai; Tao Zheng; Guangjie Wu; Si Jin
Journal:  Oxid Med Cell Longev       Date:  2014-04-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.